Biologic modification of animal models of intervertebral disc degeneration

Journal of Bone and Joint Surgery

Volumn 88, Issue SUPPL. 2, 2006, Pages 83-87

  Larson III, James W ^b   Levicoff, Eric A ^b   Gilbertson, Lars G ^b   Kang, James D ^a  

^a PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; CYTOKINE; INTERLEUKIN 6; INTERSTITIAL COLLAGENASE; NITRIC OXIDE; OSTEOGENIC PROTEIN 1; PROSTAGLANDIN E2; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TRANSFORMING GROWTH FACTOR BETA;

ADENOVIRUS VECTOR; ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; GENE THERAPY; INFLAMMATION; INTERVERTEBRAL DISK; INTERVERTEBRAL DISK DEGENERATION; INTERVERTEBRAL DISK DISEASE; NONHUMAN; NUCLEUS PULPOSUS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; VIRAL GENE DELIVERY SYSTEM;

EID: 33645563239     PISSN: 00219355     EISSN: None     Source Type: Journal    
DOI: 10.2106/00004623-200604002-00017     Document Type: Conference Paper

References (11)

1. Le Maitre CL, Freemont AJ, Hoyland JA. Localization of degradative enzymes and their inhibitors in the degenerate human intervertebral disc. J Pathol. 2004;204:47-54.
2. Burke JG, G Watson RW, Conhyea D, McCormack D, Dowling FE, Walsh MG, Fitzpatrick JM. Human nucleus pulposis can respond to a pro-inflammatory stimulus. Spine. 2003;28:2685-93.
3. Sobajima S, Shimer AL, Chadderdon RC, Kompel JF, Kim JS, Gilbertson LG, Kang JD. Quantitative analysis of gene expression in a rabbit model of intervertebral disc degeneration by real-time polymerase chain reaction. Spine J. 2005;5:14-23.
4. Paul R, Haydon RC, Cheng H, Ishikawa A, Nenadovich N, Jiang W, Zhou L, Breyer B, Feng T, Gupta P, He TC, Phillips FM. Potential use of Sox9 gene therapy for intervertebral degenerative disc disease. Spine. 2003;28:755-63.
5. Yoon ST, Park JS, Kim KS, Li J, Attallah-Wasif ES, Hutton WC, Boden SD. LMP-1 upregulates intervertebral disc cell production of proteoglycans and BMPs in vitro and in vivo. Spine. 2004;29:2603-11.
6. An HS, Takegami K, Kamada H, Nguyen CM, Thonar EJ, Singh K, Andersson GB, Masuda K. Intradiscal administration of osteogenic protein-1 increases intervertebral disc height and proteoglycan content in the nucleus pulposus in normal adolescent rabbits. Spine. 2005;30:25-31.
7. Masuda K, Imai Y, Okuma M, Muehlman C, Nakagawa K, Akeda K, Thonar E, Andersson G, An H. Osteogenic protein-1 (OP-1) injection into a degenerated disc induces the restoration of disc height and structural changes in the rabbit annular puncture model. Spine. In press.
8. Moon SH, Gilbertson LG, Nishida K, Knaub M, Muzzonigro T, Robbins PD, Evans CH, Kang JD. Human intervertebral disc cells are genetically modifiable by adenovirus-mediated gene transfer: implications for the clinical management of intervertebral disc disorders. Spine. 2000;25:2573-9.
9. Wallach CJ, Sobajima S, Watanabe Y, Kim JS, Georgescu HI, Robbins p Gilbertson LG, Kang JD. Gene transfer of the catabolic inhibitor TIMP-1 increases measured proteoglycans in cells from degenerated human intervertebral discs. Spine. 2003;28:2331-7.
10. Yang Y, Nunes FA, Berencsi K, Furth EE, Gonczol E, Wilson JM. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc Natl Acad Sci USA. 1994;91:4407-11.
11. Risbud MV, Albert TJ, Guttapalli A, Vresilovic EJ, Hillibrand AS, Vaccaro AR, Shapiro IM. Differentiation of mesenchymal stem cells towards a nucleus pulposus-like phenotype in vitro: implications for cell-based transplantation therapy. Spine. 2004;29:2627-32.